MedPath

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG logo
🇩🇪Germany
Ownership
Public, Subsidiary
Established
2002-01-01
Employees
4.8K
Market Cap
-
Website
http://www.zeiss.de

Clinical Trials

54

Active:1
Completed:34

Trial Phases

4 Phases

Phase 2:1
Phase 3:3
Phase 4:7
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (40 trials with phase data)• Click on a phase to view related trials

Not Applicable
29 (72.5%)
Phase 4
7 (17.5%)
Phase 3
3 (7.5%)
Phase 2
1 (2.5%)

Evaluation of Cataract Surgery Outcomes in Patients With Prior Laser Vision Correction Implanted With the CT LUCIA Lens

Recruiting
Conditions
Postoperative Visual Outcomes Following Cataract Surgery in Patients With Prior Myopic Corneal Laser Vision Correction
First Posted Date
2025-07-24
Last Posted Date
2025-07-24
Lead Sponsor
Carl Zeiss Meditec AG
Target Recruit Count
30
Registration Number
NCT07084545
Locations
🇺🇸

Berkeley Eye Center, Sugar Land, Texas, United States

🇺🇸

Piedmont Eye Center, Lynchburg, Virginia, United States

Evaluation of Refractive Outcomes in Patients Undergoing PRESBYOND Using the MEL90 Excimer Laser

Not yet recruiting
Conditions
Presbyopia
First Posted Date
2025-05-07
Last Posted Date
2025-05-07
Lead Sponsor
Carl Zeiss Meditec AG
Target Recruit Count
75
Registration Number
NCT06960785
Locations
🇦🇺

Eye Laser Specialists, Melbourne, VIC/Australia, Australia

🇦🇺

Crystal Eye and laser Center, Craigie, Western Australia, Australia

🇳🇿

The Wellington Eye Centre, Wellington, New Zealand

Evaluation of a Monofocal Intraocular Lens

Phase 4
Recruiting
Conditions
Cataract
First Posted Date
2024-05-24
Last Posted Date
2024-06-24
Lead Sponsor
Carl Zeiss Meditec AG
Target Recruit Count
44
Registration Number
NCT06428955
Locations
🇺🇸

Price Vision Group, Indianapolis, Indiana, United States

🇺🇸

Huffman & Huffman PSC, Lexington, Kentucky, United States

🇺🇸

The Pennsylvania State University and Penn State Health, Hershey, Pennsylvania, United States

and more 1 locations

Study to Confirm Safety and Performance of a New Multifocal IOL

Not Applicable
Completed
Conditions
Cataract Senile
First Posted Date
2024-02-08
Last Posted Date
2024-11-27
Lead Sponsor
Carl Zeiss Meditec AG
Target Recruit Count
135
Registration Number
NCT06247683
Locations
🇨🇿

Nemocnice Havlíčkův, Havlíčkův Brod, Czechia

🇨🇿

Oční Centrum Praha, Prague, Czechia

🇨🇿

Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha, Prague, Czechia

and more 8 locations

Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses After Bilateral Cataract Surgery

Completed
Conditions
Senile Cataract
First Posted Date
2024-01-05
Last Posted Date
2024-01-05
Lead Sponsor
Carl Zeiss Meditec AG
Target Recruit Count
8
Registration Number
NCT06192901
Locations
🇸🇻

Clinica Quesada, San Salvador, El Salvador

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

News

ZEISS CLARUS 700 Ultra-Widefield Retinal Imaging System Receives NMPA Approval in China

ZEISS Medical Technology announced that its CLARUS 700 ultra-widefield fundus imaging camera has received National Medical Products Administration (NMPA) approval in China, expanding access to advanced retinal diagnostic capabilities.

ZEISS Medical Technology's ILM-Blue Receives NMPA Approval in China, Expanding Surgical Options for Retinal Surgeons

ILM-Blue, a vital staining dye used in vitreoretinal surgery, has received NMPA approval in China, becoming the first DORC posterior dye product available in the Chinese market.

ZEISS VISUMAX 800 with SMILE Pro Receives NMPA Approval for Laser Vision Correction in China

ZEISS Medical Technology has secured NMPA approval in China for the VISUMAX 800 with SMILE pro software, designed to treat nearsightedness with or without astigmatism.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.